Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy. Results of the first prospective pilot study;Rôle de l'Helicobacter pylori dans la choriorétinopathie séreuse centrale et l'épithéliopathie rétinienne diffuse: Résultats de la première étude prospective pilote

Journal Francais d'Ophtalmologie

Volumn 25, Issue 10, 2002, Pages 1021-1025

  Mauget Faysse M ^a   Kodjikian, L ^b   Quaranta, M ^a   Ben Ezra, D ^c   Trepsat, C ^b   Mion, F ^b   Megraud F ^d  

^a Centre Ophtalmologique Rabelais   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d HÔPITAL PELLEGRIN   (France)

Author keywords

Central serous chorioretinopathy; Diffuse retinal epitheliopathy; Helicobacter pylori infection; Urea breath test

Indexed keywords

CARBON 13;

ADULT; AGED; ARTICLE; CENTRAL SEROUS RETINOPATHY; CHOROID CAPILLARY LAYER; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; FEMALE; FRANCE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MALE; PATHOGENESIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PROSPECTIVE STUDY; RETINA PIGMENT EPITHELIOPATHY; SEROLOGY; STOMACH BIOPSY; STOMACH PAIN; UREA BREATH TEST;

ADULT; AGED; CHORIORETINITIS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PIGMENT EPITHELIUM OF EYE; PILOT PROJECTS; PROSPECTIVE STUDIES; RETINAL DISEASES;

EID: 17944398688     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium. Idiopathic central serous chorioretinopathy. Am J Ophthalmol, 1960;63:587-615.
2. Spitznas M. Pathogenesis of central serous retinopathy: a new working hypothesis. Graefes Arch Clin Exp Ophthalmol, 1986;224:321-4.
3. Marmor MF. Control of subretinal fluid: experimental and clinical studies. Eye, 1990;4:340-4.
4. Spaide RF, Hall LS, Hass A et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina, 1996;16:203-13.
5. Hayashi K, Hasegana Y, Tokoro T. Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol, 1996;9:37-41.
6. Prünte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol, 1996;121:26-34.
7. Guyer DR, Yannuzzi LA, Slakter JS. Digital indocyanine green angiography of central serous chorioretinopathy. Arch Ophthalmol, 1994;112:1057-62.
8. Tran VT. Human retinal pigment epithelial cells possess beta-2 adrenergic receptors. Exp Eye Res, 1992;55:413-7.
9. Nagayoski K. Experimental study of chorioretinopathy by intravenous injection of adrenaline. Acta Soc Ophthalmol Jpn, 1971;75:1720-7.
10. Libby P, Egan D, Skarlatos S. Role of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation, 1997;96:4095-103.
11. Uyama M, Matsunaga H, Matsubara T, Fukushima I, Takahashi K, Nishimura T. Indocyanine green angiography and pathophysiology of multifocal posterior pigment epitheliopathy. Retina, 1999;19:12-21.
12. Spaide RF, Campeas L, Haas A et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology, 1996;103:2070-80.
13. Baumal CR. Clinical applications of optical coherence tomography. Curr Opin Ophthalmol, 1999;10:182-8.
14. 13C pour le diagnostic de l'infection à Helicobacter pylori: comparaison avec l'histologie. Gastroenterol Clin Biol, 1994;18:1106-11.
15. 13C-urea breath test for Helicobacter pylori: cut-off point determination by cluster analysis. Clin Sci, 1997;93:3-6.
16. Lamouliatte H, Mégraud F. L'éradication de H. pylori. Mise au point. Le quotidien du médecin, 1998;6312:4-5.
17. Mendall MA, Goggin PM, Molineaux N et al. Relation of H. pylori infection to coronary artery disease. Br Heart J, 1994;71:433-7.
18. Morgando A, Sanseverino P, Peretto C, Molino F, Gai V, Ponzetto A. H. pylori seropositivity in myocardial infarction. Lancet, 1995; 345:1380.
19. Martin-De-Argila C, Boixeda D, Canton R, Gilbert JP, Fuertes A. High seroprevalence of H. pylori infection in coronary heart disease. Lancet, 1995;346:310.
20. Markus HS, Mendall MA. H. pylori infection: a risk factor for ischaemic cerebro-vascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry, 1998;64:104-7.
21. Danesh J, Peto R. Risk factors for coronary heart disease and infection with H. pylori: meta-analysis of 18 studies. BMJ, 1998;316:1130-2.
22. Elizalde JI, Gomez J, Panes J, Lozano M, Casadevall M, Ramirez J et al. Platelet activation in mice and human H. pylori infection. J Clin Invest, 1997;100:996-1005.
23. Miragliotta G, Del Prete R, Mosca A. H. pylori and coronary heart disease. Lancet, 1994;344:751.
24. Sung JJK, Sanderson JE. Hyperhomocysteinaemia, H. pylori and coronary heart disease. Heart, 1996;76:305-7.
25. Broutet N, Sarasqueta AM, Cantet F, Lethuaire D, Mégraud F. Is there a link between the variation in gastric cancer mortality and differences in H. pylori prevalence in different regions of France? Gastroenterol Clin Biol, 1999;23:754-60.
26. Mégraud F, Brassens-Rabbé MP, Denis F, Belbouri A, Hoa DQ. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol, 1989;27:1870-3.
27. Giusti C. La corioretinopatia sierosa centrale: una nuova manifestazione extradigestiva de l'Helicobacter pylori? Analisi di un caso clinico. Clin Ter, 2001;152:1-5.